Owner Yissum Research Development Company of The Hebrew University of Jerusalem Medical Research Fund at the Tel Aviv Sourasky Medical Center

Inventors Caspi, Dan; Golan, Itshak; Melnik, Lora

Agent Cullen & Co

Pub. Number AU-B-2005201964

Parent 2003279511

Filing date 10 May 2005

Wipo publication date 26 May 2005

Acceptance publication date 4 June 2009

C12N 1/20 (2006.01) Micro-organisms, e.g. protozoa - Bacteria

A61K 38/00 (2006.01) Medicinal preparations containing peptides

C07H 21/04 (2006.01) Compounds containing two or more mononucleotide units having separate phosphate or polyphosphate groups linked by saccharide radicals of nucleoside groups, e.g. nucleic acids

C07K 16/28 (2006.01) Immunoglobulins, e.g. monoclonal or polyclonal antibodies

C12N 15/74 (2006.01) Mutation or genetic engineering - Vectors or expression systems specially adapted for prokaryotic hosts other than E. coli, e.g. Lactobacillus, Micromonospora

C12P 21/06 (2006.01) Preparation of peptides or proteins - produced by the hydrolysis of a peptide bond, e.g. hydrolysate products

C12Q 1/68 (2006.01) Measuring or testing processes involving enzymes or micro-organisms - involving nucleic acids